Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer

다국어 초록 (Multilingual Abstract)

Multi-parametric magnetic resonance imaging (mpMRI) has been increasingly used to diagnose clinically significant prostate cancer (csPCa) because of its growing availability and its ability to combine anatomical and functional data. Magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion imaging provides MRI information with TRUS images for prostate biopsies. This technique combines the superior sensitivity of MRI for targeting suspicious lesions with the practicality and familiarity of TRUS. MRI-TRUS fusion image-guided prostate biopsy is performed with different types of image registration (rigid vs. elastic) and needle tracking methods (electromagnetic tracking vs. mechanical position encoders vs. image-based software tracking). A systematic review and meta-analysis showed that MRI-targeted biopsy detected csPCa at a significantly higher rate than did TRUS-guided biopsy, while it detected significantly fewer cases of insignificant PCas. In addition to the high accuracy of MRI-targeted biopsy for csPCa, localization of csPCa is accurate. The ability to choose the route of biopsy (transperineal vs. transrectal) is required, depending on the patients' risk and the location and size of suspicious lesions on mpMRI. Fusion image-guided prostate biopsy has the potential to allow precise management of prostate cancer, including active surveillance, radical treatment, and focal therapy.

참고문헌 (Reference)

1 Sciarra A, "Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy" 16 : 1875-1883, 2010

2 Vilanova JC, "Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer" 196 : W715-22, 2011

3 Hamoen EH, "Use of the Prostate Imaging Reporting and Data System(PIRADS)for prostate cancer detection with multiparametric magnetic resonance imaging : a diagnostic meta-analysis" 67 : 1112-1121, 2015

4 Barret E, "Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer" 2018

5 Smith JB, "Transperineal sector prostate biopsies : a local anesthetic outpatient technique" 83 : 1344-1349, 2014

6 Kasivisvanathan V, "Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer" 189 : 860-866, 2013

7 Toi A, "The continuing importance of transrectal ultrasound identification of prostatic lesions" 177 : 516-520, 2007

8 Sonn GA, "Target detection : magnetic resonance imaging-ultrasound fusion-guided prostate biopsy" 32 : 903-911, 2014

9 Moore CM, "Standards of reporting for MRI-targeted biopsy studies(START)of the prostate : recommendations from an International Working Group" 64 : 544-552, 2013

10 Haffner J, "Role of magnetic resonance imaging before initial biopsy : comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection" 108 : E171-E178, 2011

11 Hung AJ, "Robotic transrectal ultrasonography during robot-assisted radical prostatectomy" 62 : 341-348, 2012

12 Hambrock T, "Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer" 259 : 453-461, 2011

13 Rosenkrantz AB, "Prostate cancer foci detected on multiparametric magnetic resonance imaging are histologically distinct from those not detected" 187 : 2032-2038, 2012

14 Labanaris AP, "Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate" 13 : 65-70, 2010

15 Oto A, "Prostate cancer : differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging" 257 : 715-723, 2010

16 Steiger P, "Prostate MRI based on PI-RADS version 2 : how we review and report" 16 : 9-, 2016

17 Park BK, "Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy" 197 : W876-W881, 2011

18 Delongchamps NB, "Prebiopsy magnetic resonance imaging and prostate cancer detection : comparison of random and targeted biopsies" 189 : 493-499, 2013

19 Gangi A, "Percutaneous MR-guided cryoablation of prostate cancer : initial experience" 22 : 1829-1835, 2012

20 Weinreb JC, "PI-RADS prostate imaging-reporting and data system : 2015, version 2" 69 : 16-40, 2016

21 van den Bergh RC, "Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly" 55 : 1-8, 2009

22 Hara R, "Optimal approach for prostate cancer detection as initial biopsy : prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy" 71 : 191-195, 2008

23 Radtke JP, "Multiparametric magnetic resonance imaging(MRI)and MRI-transrectal ultrasound fusion biopsy for index tumor detection : correlation with radical prostatectomy specimen" 70 : 846-853, 2016

24 Delongchamps NB, "Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer : combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging" 107 : 1411-1418, 2011

25 Shoji S, "Manually controlled targeted prostate biopsy with realtime fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound : an early experience" 22 : 173-178, 2015

26 Kongnyuy M, "Magnetic resonance imaging-ultrasound fusion-guided prostate biopsy : review of technology, techniques, and outcomes" 17 : 32-, 2016

27 Baco E, "Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor : correlation with step-sectioned radical prostatectomy specimens in 135 patients" 67 : 787-794, 2015

28 Schoots IG, "Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasoundguided biopsy : a systematic review and meta-analysis" 68 : 438-450, 2015

29 Hambrock T, "Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen" 183 : 520-527, 2010

30 Dickinson L, "Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer : recommendations from a European consensus meeting" 59 : 477-494, 2011

31 Stavrinides V, "MRI in active surveillance: a critical review" 2018

32 Rud E, "MRI and ultrasound-guided prostate biopsy using soft image fusion" 32 : 3383-3389, 2012

33 Mohler JL, "Joint statement by members of the NCCN Prostate Cancer Guidelines Panel" 11 : 1310-1312, 2013

34 Turkbey B, "Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images" 258 : 488-495, 2011

35 Mottet N, "Implementing newer agents for the management of castrateresistant prostate cancer : what is known and what is needed" 115 : 364-372, 2015

36 Moore CM, "Image-guided prostate biopsy using magnetic resonance imaging-derived targets : a systematic review" 63 : 125-140, 2013

37 Shoji S, "Image-based monitoring of targeted biopsy-proven prostate cancer on active surveillance : 11-year experience" 34 : 221-227, 2016

38 Shoji S, "Handbook of Focal Therapy for Prostate and Renal Cancer" JP Medical Ltd 241-254, 2016

39 Muto S, "Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer" 38 : 192-199, 2008

40 Ahmed HU, "Focal therapy for localized prostate cancer : a phase I/II trial" 185 : 1246-1254, 2011

41 Ahmed HU, "Focal therapy for localised unifocal and multifocal prostate cancer : a prospective development study" 13 : 622-632, 2012

42 Steensels D, "Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy-should we reassess our practices for antibiotic prophylaxis" 18 : 575-581, 2012

43 Mozer P, "First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer" 115 : 50-57, 2015

44 Junker D, "Evaluation of the PI-RADS scoring system for mpMRI of the prostate : a whole-mount step-section analysis" 33 : 1023-1030, 2015

45 Tewes S, "Evaluation of MRI/ultrasound fusion-guided prostate biopsy using transrectal and transperineal approaches" 2017 : 2176471-, 2017

46 Venderink W, "Elastic versus rigid image registration in magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy : a systematic review and meta-analysis" 4 : 219-227, 2018

47 Barentsz JO, "ESUR prostate MR guidelines 2012" 22 : 746-757, 2012

48 Collins DJ, "Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges" 23 : 65-83, 2004

49 Hara N, "Dynamic contrast-enhanced magnetic resonance imaging(DCEMRI)is a useful modality for the precise detection and staging of early prostate cancer" 62 : 140-147, 2005

50 Oberlin DT, "Diagnostic value of guided biopsies: fusion and cognitive-registration magnetic resonance imaging versus conventional ultrasound biopsy of the prostate" 92 : 75-79, 2016

51 Rud E, "Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging(MRI)alone" 114 : E32-E42, 2014

52 Logan JK, "Current status of magnetic resonance imaging(MRI)and ultrasonography fusion software platforms for guidance of prostate biopsies" 114 : 641-652, 2014

53 Zelhof B, "Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer" 103 : 883-888, 2009

54 Gibbs P, "Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla" 44 : 572-576, 2009

55 Humphrey PA, "Complete histologic serial sectioning of a prostate gland with adenocarcinoma" 17 : 468-472, 1993

56 Huang H, "Comparison of the complications of traditional 12 cores transrectal prostate biopsy with image fusion guided transperineal prostate biopsy" 16 : 68-, 2016

57 Siddiqui MM, "Comparison of MR/ultrasound fusionguided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer" 313 : 390-397, 2015

58 Le-Hang Guo, "Comparison between Ultrasound Guided Transperineal and Transrectal Prostate Biopsy: A Prospective, Randomized and Controlled Trial" Springer Science and Business Media LLC 5 (5): 2015

59 Wegelin O, "Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging- transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique" 71 : 517-531, 2017

60 Porten SP, "Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer" 186 : 1825-1829, 2011

61 Sciarra A, "Advances in magnetic resonance imaging : how they are changing the management of prostate cancer" 59 : 962-977, 2011

62 Shoji S, "Accuracy of real-time magnetic resonance imagingtransrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical positionencoded stepper in detecting significant prostate cancer in biopsy-naïve men" 24 : 288-294, 2017

63 van As NJ, "A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance" 56 : 981-987, 2009

64 Wysock JS, "A prospective, blinded comparison of magnetic resonance(MR)imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy : the PROFUS trial" 66 : 343-351, 2014

65 Takenaka A, "A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy" 11 : 134-138, 2008